Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) Expects to Submit European Union Marketing Application in H2 for Epidiolex in Lennox-Gastaut Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 29, 2017
Occurred Source:
https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-submits-marketing-authorisation-application-europe-epidiolex%C2%AE
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Union, Marketing Application, Epidiolex, Lennox-gastaut Syndrome
